Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therap...
Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis
About this item
Full title
Author / Creator
Ocal, Nesrin , Cilli, Aykut , Mogulkoc, Nesrin , Coskun, Funda , Ursavas, Ahmet , Hanta, Ismail , Ozyurek, Berna Akinci , Ensarioglu, Kerem , Ezircan, Alper , Yuksel, Esra , Arikan, Beste , Uzer, Fatih , Ozdemirel, Tugce Sahin , Misirci, Salim , Deniz, Pelin Pinar , Basyigit, Ilknur and Kumbasar, Ozlem Ozdemir
Publisher
India: Wolters Kluwer - Medknow
Journal title
Language
English
Formats
Publication information
Publisher
India: Wolters Kluwer - Medknow
Subjects
More information
Scope and Contents
Contents
ABSTRACT
BACKGROUND:
There are still disagreements about diagnostic criteria and treatment of progressive pulmonary fibrosis (PPF). Real-life data and survival analyses have a guiding role in clarifying this issue.
METHODS:
In this multicenter retrospective cohort study, real-life data of adult patients diagnosed with PPF and treated wi...
Alternative Titles
Full title
Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5b13d5f6b61e4283a2da3d347b687b64
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5b13d5f6b61e4283a2da3d347b687b64
Other Identifiers
ISSN
1817-1737
E-ISSN
1998-3557
DOI
10.4103/atm.atm_213_24
